Our team has decades of experience as entrepreneurs, advisors, corporate executives and board directors. We are passionate about accelerating the growth of our portfolio businesses.
Daniella Kranjac has been building life sciences businesses, developing and commercializing life sciences products for 20 years. Having co-founded Wave Biotech LLC from her dormitory room, she and a partner drove the start-up, growth and commercialization of a highly disruptive technology. As Vice President of the organization, Daniella established a high growth company with significant brand recognition, and led the group to a successful exit and acquisition by GE Healthcare in 2007.
Reinhard Vogt was most recently the Executive VP and Member of the Board of Sartorius Stedim Biotech S.A, a leading international partner to biotechnology and pharmaceutical companies, providing critical solutions for research, development and manufacturing. Reinhard brings a wealth of industry knowledge, technology deal-side expertise and numerous technology licenses, acquisitions and integrations derived from one of the industry’s largest players. What this means to investors and portfolio companies is a winning combination of commercial and operational support owed to Reinhard’s experience with more than a dozen high-profile, accretive deals throughout his time at Sartorius.
For 25 years, Mario Kranjac has been counseling privately held businesses in law and business matters relating to mergers and acquisitions, corporate finance, raising of capital, securities, asset-based and project financing, technology licensing, contracts, and commercial transactions. Kranjac Tripodi & Partners LLP provides focused advice to both investors and entrepreneurs from inception through to negotiation of partner separation and liquidity events, providing value every step of the way.
Dynamk Capital has assembled a team of Advisors with deep expertise in life sciences and biotech business operations, technology and manufacturing, as well as venture, private equity and deal assessment. These advisors are domain experts in bioscience, discovery, development and commercialization of therapeutics, bioprocess tools and services and platform technologies. We leverage our broad network of subject matter experts for opportunity assessment and supporting the growth of the companies in our portfolio.
Former Vice President, Process Development and Preclinical Manufacturing, Regeneron
Former President, Pfizer Global Supply, Pfizer, Inc.
CEO, BiologicB LLC, former Vice President, Bioprocess Research & Development, Merck & Co., Inc.
CEO, CMC Biologics / AGC Asahi Glass
Dynamk partners with domain experts, providing valuable guidance to our fund.
All trademarks are the property of their respective owners.